Intellipharmaceutics International Inc.: Intellipharmaceutics Reports Director Election Results

Intellipharmaceutics International Inc.: Intellipharmaceutics Reports Director Election Results
TORONTO, ON / ACCESSWIRE / December 23, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, reports, as required by TSX rules, that the six nominees, each of whom was an incumbent director of the Company, identified in the Management Information Circular dated November 9, 2020 (the "Circular") were elected as directors of the Company at the annual meeting of shareholders of the Company held today (the "Meeting"). The voting results, as set out in the scrutineer's report for the Meeting, were as follows:

Related Keywords

United States ,Canada ,Toronto ,Ontario ,Shawn Graham ,Isa Odidi ,Amina Odidi ,Kenneth Keirstead ,Norman Betts ,See The Company Report On Voting ,Company Contact ,Intellipharmaceutics International Inc ,Intellipharmaceutics International ,Management Information Circular ,Voting Results ,Point Of Divergence Drug Delivery System ,Securities Act ,ஒன்றுபட்டது மாநிலங்களில் ,கனடா ,டொராண்டோ ,ஆஂடேரியொ ,ஷான் கிரஹாம் ,நார்மன் பந்தயம் ,பார்க்க தி நிறுவனம் அறிக்கை ஆன் வாக்களித்தல் ,நிறுவனம் தொடர்பு ,மேலாண்மை தகவல் வட்ட ,வாக்களித்தல் முடிவுகள் ,பத்திரங்கள் நாடகம் ,